Hyperinsulinemia and hypofibrinolysis: Effects of short-term optimized glycemic control with continuous insulin infusion in type II diabetic patients

Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis

Katherine A. Hajjar, Dov Gavishi, Jan L. Breslow et al. · Nature · 1989 · 705 citations

Veterinary Medicine, Cell Biology, Physiology +14

The Effect of Insulin Treatment on Insulin Secretion and Insulin Action in Type II Diabetes Mellitus

W. Timothy Garvey, Jerrold M. Olefsky, Justin W. Griffin et al. · Diabetes · 1985 · 471 citations

Medicine, Endocrinology, Internal Medicine +16

Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects

P Vague, I. Juhan‐Vague, Marie Françoise Aillaud et al. · Metabolism · 1986 · 448 citations

Medicine, Endocrinology, Physiology +9

Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity.

Sally J. Dawson, Anders Hamsten, B. Wiman et al. · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · 1991 · 322 citations · Full text

Medicine, Genetics, Molecular Genetics +13

Elevated fibrinogen and plasminogen activator inhibitor (PAI‐1) in hypertension are related to metabolic risk factors for cardiovascular disease

Lilian Tengborn, Ulf Smith · Journal of Internal Medicine · 1990 · 309 citations

Medicine, Endocrinology, Diabetology +10